Clinical trials
Completed Pathologic Processes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
99 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 12 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 6 |
| 2014 | 3 |
| 2015 | 7 |
| 2016 | 4 |
| 2017 | 11 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 9 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 99 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 3 |
| Vertex Pharmaceuticals Incorporated | 3 |
| AO GENERIUM | 2 |
| Aeris Therapeutics | 2 |
| Bausch Health Americas, Inc. | 2 |
| Neuroscience Trials Australia | 2 |
| Olympus Corporation of the Americas | 2 |
| University of Pittsburgh | 2 |
| University of Washington, the Collaborative Health Studies Coordinating Center | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pathologic Processes | 99 |
| Cardiovascular Diseases | 18 |
| Lung Diseases | 16 |
| Inflammation | 15 |
| Respiratory Tract Diseases | 15 |
| Digestive System Diseases | 14 |
| Heart Diseases | 14 |
| Nervous System Diseases | 14 |
| Genetic Diseases, Inborn | 10 |
| Arrhythmias, Cardiac | 9 |
Trials
Showing 1 to 25 of 99. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.